Migraine: Mining the Outer Reaches of Headache Science

Need

In order to elevate patient care for migraine, it is imperative that headache specialists gain expertise in clinical trial data for new therapies, mechanisms of action, and clinical practice standards. This is especially true as we approach the first year of monoclonal antibodies being available in clinical practice that block the activity of calcitonin gene-related peptide. Competency in patient engagement strategies will serve as a lever to propel the expanding knowledge base into meaningful change in migraine-patient care.

Activity

July 25, 2019, Lake Buena Vista, Florida
60-minute live forum featuring Microsoft HoloLens, a mixed reality device
Review of clinical cases, applications to clinical decision making, and shared decision making techniques
Delivered in conjunction with Diamond Headache Clinic Research & Educational Foundation Meeting, Headache Update

Goal

Educate headache specialists on the pathophysiology and mechanisms of action of acute and preventive migraine treatments.

Outcomes (n=99)

97%

of attendees reported that the activity was applicable to improving their professional practice

97%

of attendees rated the scientific/technical level of the HoloLens mixed reality feature as appropriate

90%

of attendees reported that the HoloLens mixed reality feature enhanced their learning experience

Faculty

Merle L. Diamond, MD

Chicago, Illinois

Wade M. Cooper, DO

Ann Arbor, Michigan

Stewart J. Tepper, MD

Lebanon, New Hampshire